Global Injectable Nanomedicines Market Insights, Deep Analysis of Key Vendor in the Industry 2018-2025
The Global Injectable
Nanomedicines market was valued at USD 479.6 million in 2017, and is
projected to reach USD 833.9 million by the end of 2025, growing at a CAGR of
7.3% during 2018–2025.The key factor bolstering the injectable nanomedicines
market growth is increase in the incidence of chronic diseases like cancer, cardiovascular
diseases, etc. Extensive R&D activities coupled with a lot of clinical
trials is also aiding the growth of the market. In addition, the continuous
growth in demand for minimally invasive treatments along with large patient
pool of geriatric population has further fuelling the growth of global
injectable nanomedicines market share.
Based on Drug Type, Liposomes
segment held the largest market share in 2017 and is expected to dominate the
market during the forecast period. The Liposomes segment is expected to
dominate the market due to extensive R&D activities in liposomal drug
delivery systems which further favour development of injectable nanomedicines.
In addition, efficacy and improved disease management coupled with targeted
drug delivery is expected to fuel the demand of injectable medicine. The
Nanocrystals segment held the second largest market share in 2017 and is
expected to grow at the fastest rate during the forecast period.
Request for Sample Report https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/sample-request
North America is the biggest
market in 2017 due to factors such as a significantly high rate of incidence of
cancer as well as cardiovascular diseases, growing demand for rapid R&D of
novel nanomedicine in order to address unmet medical needs. Europe has
registered a significant growth rate in global injectable nanomedicines market
and held the second highest market shares in 2017. Asia-Pacific is expected to
show promising growth in global injectable nanomedicines during 2018-2025 due
to the increase in government and private funding on health care infrastructure
along with the rising incidence of neurological disorders. Moreover, increasing
adoption of nanomedicine for the treatment of cancer, diabetes, cardiovascular
diseases and some infectious disease in the Asia-Pacific region would also
contribute significantly to the market growth for injectable nanomedicines in
the region.
Various
notable players operating in the market include Merck & Co., Inc., Lupin,
Pacira Pharmaceuticals Inc., Celgene Pharmaceutical Co. Ltd., Amgen, Inc.,
Janssen Biotech Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical
Industries Ltd., Bausch & Lomb Inc. among others among others.
Request for Customization – https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/request-for-customization
The research report “Global Injectable Nanomedicines Market”
provides in-depth analysis of injectable nanomedicines market, globally, based
on product type, indication and major geographies for the forecast period from
2018 to 2025. The report highlights the major market drivers fuelling the
growth as well as challenges faced by the market participants. The research
report provides market size and forecast for injectable nanomedicines market.
The report also analyses the competitive landscape, major players and their
strategies in 2018. The competitive landscape section of the report captures
and highlights the recent developments in the market.
Key questions answered in this
research report:
1- At what pace is injectable nanomedicines market growing, globally? What will be the growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the injectable nanomedicines market?
4- What are the various application areas and how they are poised to grow?
1- At what pace is injectable nanomedicines market growing, globally? What will be the growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the injectable nanomedicines market?
4- What are the various application areas and how they are poised to grow?
For Additional Insights, Click to Access
Complete Report - https://www.gmiresearch.com/report/global-injectable-nanomedicines-market-by-product/
About GMI Research
GMI Research
is a market research and consulting firm which provides research-based
solutions to business executives and investment professionals so that they can
make right business & investment decisions faster based on real facts. We
help business leaders through independent fact-based insight, ensuring their
business achieve success by beating the competition. GMI Research’s leadership
team with extensive experience in research and consulting together with our
research and domain expertise creates a strong value proposition to create
solutions that addresses our clients business problems and add significant value
to long lasting relationship.
The company
provides syndicated research report, customized research, sales enablement
research, data analytics and KPO (knowledge process outsourcing) service for
Electronics & Semiconductors, Information Communication and Technology,
Energy & Power, Healthcare, Automotive, Transportation & Logistics and
Chemical industries. Our analysts and consultants who are passionate about
research and consulting are recruited from renowned local and global
universities and have worked with the leading local and international
organizations.
Contact Us
Email: enquiry@gmiresearch.com
Phone: +353
1 442 8820
Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate
City: Dublin
State: Dublin
Country: Ireland
Website: www.gmiresearch.com
Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate
City: Dublin
State: Dublin
Country: Ireland
Website: www.gmiresearch.com
Comments
Post a Comment